Complex I (NADH-ubiquinone oxidoreductase) serves as the main entry point for reoxidation NADH produced by the anaerobic phase of metabolism; it is the most complicated and least studied energy transducing device of the mitochondrial respiratory chain. The P.I.s propose to continue studying the molecular mechanism of electron/vectorial proton transfer in mammalian Complex I. The structure/function rearrangements involved in the """"""""active"""""""" (pulsed) - """"""""inactive"""""""" (resting) state transition of Complex I will also be studied. This work constitutes one of the physiologically most important research areas, since many diseases in highly energy-demanding tissues are associated with inherited or induced defects in Complex I. Specific new directions of the proposed work include: (1) studies on the substrate (pyridine nucleotide binding site(s), which will be conducted by measuring kinetic parameters of NADH dehydrogenation utilizing competitive NAD+ and NADH analogues. The dependence of the binding site affinities for catalytically inert nucleotides on the enzyme redox state(s) will also be investigated; (2) determination of the spatial organization of EPR-detectable redox components relative to each other and to the surfaces of the energy transducing membrane, with a special emphasis on the two distinct species of delta-mu(H+)-dependent, complex I-associated ubisemiquinones, which have recently been discovered in the P.I. and Co-P.I.'s collaborative endeavor; (3) identification of the polypeptide(s) involved in the slow inactive/active transition of Complex I utilizing specific labelling with fluorescent and spectrally- detectable SH-reagents; (4) development of a procedure for solubilization and purification of the enzyme stabilized in the active conformation by using specific inhibitors which bind exclusively or preferentially to active Complex I. The U.S. P.I. has extensive experience in cryogenic EPR (the only technique which is presently available for studies of Complex I redox components in situ) and in thermodynamic analysis of the respiratory chain components. The P.I. has made significant contributions in the analysis of iron-sulfur proteins, flavin, and semiquinone free radicals. The Co-P.I. has extensive experience in preparative biochemistry of redox enzymes and in enzyme kinetic analysis. The collaborative project between these investigators will greatly enhance the progress in understanding the molecular mechanisms of energy-transduction in Complex I and its physiologically relevant regulation.

Agency
National Institute of Health (NIH)
Institute
Fogarty International Center (FIC)
Type
Small Research Grants (R03)
Project #
5R03TW000140-06
Application #
2736201
Study Section
International and Cooperative Projects 1 Study Section (ICP)
Project Start
1993-07-01
Project End
1999-12-31
Budget Start
1998-07-01
Budget End
1999-12-31
Support Year
6
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Biochemistry
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Magnitsky, Sergey; Toulokhonova, Larisa; Yano, Takahiro et al. (2002) EPR characterization of ubisemiquinones and iron-sulfur cluster N2, central components of the energy coupling in the NADH-ubiquinone oxidoreductase (complex I) in situ. J Bioenerg Biomembr 34:193-208
Gavrikova, E V; Vinogradov, A D (1999) Active/de-active state transition of the mitochondrial complex I as revealed by specific sulfhydryl group labeling. FEBS Lett 455:36-40
Vinogradov, A D; Gavrikova, E V; Grivennikova, V G et al. (1999) Catalytic properties of mitochondrial NADH-ubiquinone reductase (Complex I). Biochemistry (Mosc) 64:136-52
Galkin, A S; Grivennikova, V G; Vinogradov, A D (1999) -->H+/2e- stoichiometry in NADH-quinone reductase reactions catalyzed by bovine heart submitochondrial particles. FEBS Lett 451:157-61
Zakharova, N V; Zharova, T V; Vinogradov, A D (1999) Kinetics of transhydrogenase reaction catalyzed by the mitochondrial NADH-ubiquinone oxidoreductase (Complex I) imply more than one catalytic nucleotide-binding sites. FEBS Lett 444:211-6
Ushakova, A V; Grivennikova, V G; Ohnishi, T et al. (1999) Triton X-100 as a specific inhibitor of the mammalian NADH-ubiquinone oxidoreductase (Complex I). Biochim Biophys Acta 1409:143-53
Vinogradov, A D (1998) Catalytic properties of the mitochondrial NADH-ubiquinone oxidoreductase (complex I) and the pseudo-reversible active/inactive enzyme transition. Biochim Biophys Acta 1364:169-85
Grivennikova, V G; Maklashina, E O; Gavrikova, E V et al. (1997) Interaction of the mitochondrial NADH-ubiquinone reductase with rotenone as related to the enzyme active/inactive transition. Biochim Biophys Acta 1319:223-32
Zharova, T V; Vinogradov, A D (1997) A competitive inhibition of the mitochondrial NADH-ubiquinone oxidoreductase (complex I) by ADP-ribose. Biochim Biophys Acta 1320:256-64
Gavrikova, E V; Grivennikova, V G; Sled, V D et al. (1995) Kinetics of the mitochondrial three-subunit NADH dehydrogenase interaction with hexammineruthenium(III). Biochim Biophys Acta 1230:23-30

Showing the most recent 10 out of 13 publications